Assignee
JURE-KUNKEL MARIA
US·6 granted patents·2 pending applications·341 citations·filing 2009–2012
Top patents by PatentIndex Score
8 records- 0198US8119129B2Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2009·Granted Feb 21, 2012·165 cites·11 claims
- 0297US8685394B2Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2009·Granted Apr 1, 2014·28 cites·10 claims
- 0396US8716452B2Fully human antibodies against human 4-1BBJURE-KUNKEL MARIA·Filed 2012·Granted May 6, 2014·41 cites·3 claims
- 0496US8475790B2Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2009·Granted Jul 2, 2013·57 cites·8 claims
- 0596US8137667B2Fully human antibodies against human 4-1BBJURE-KUNKEL MARIA·Filed 2009·Granted Mar 20, 2012·39 cites·3 claims
- 0692US8449886B2Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2009·Granted May 28, 2013·11 cites·5 claims
- 0764US2012135001A1Combination of anti-ctla4 antibody with dasatinib for the treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2012·Application pending·0 cites
- 0846US2013156768A1Combination of anti-ctla4 antibody with braf inhibitors for the synergistic treatment of proliferative diseasesJURE-KUNKEL MARIA·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →